Advertisement

Differential Diagnosis of Hypopyon Uveitis

  • Aniruddha Agarwal
  • Ilaria Testi
  • Ankur Singh
  • Vishali GuptaEmail author
Living reference work entry

Abstract

Hypopyon that complicates the course of uveitis must make aware of potential systemic associations and conditions that could require a prompt management. A stepwise diagnostic approach guided by medical history and clinical examination together with conscious interpretation of tests results is mandatory to guide the physician in the differentiation between infective, inflammatory, and neoplastic disorders. Timely therapeutic management is essential to avoid serious sequelae for patients in terms of poor visual prognosis and lifetime expectancy.

Suggested Reading

  1. Accorinti M, Pesci FR, Pirraglia MP, Abicca I, Pivetti-Pezzi P. Ocular Behçet’s disease: changing patterns over time, complications and long-term visual prognosis. Ocul Immunol Inflamm. 2017;25(1):29–36.PubMedCrossRefGoogle Scholar
  2. Ahn SJ, Ryoo NK, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy. 2014;4(3):134–41.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Alkatan HM, Al-Dhibi HA, Edward DP, Al-Rajhi AA. Pigmented hypopyon in association with Listeria monocytogenes endopthalmitis: an interesting case report following refractive surgery procedure with literature review. Middle East Afr J Ophthalmol. 2014;21(1):40–3.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Alten F, Ehlert K, Böhm MR, Grenzebach UH. Leukemic hypopyon in acute myeloid leukemia. Eur J Ophthalmol. 2013;23(2):252–4.PubMedCrossRefGoogle Scholar
  5. Bronner A, Risse JF, Philippot J, Gerhard JP, Flament J. Hypertensive uveitis with hemorrhagic hypopyon revealing chronic lymphoid leukemia (discussion of a case). Bull Soc Ophtalmol Fr. 1976;76(2):201–4.Google Scholar
  6. Cunningham C, Widder J, Raiji V. Endophthalmitis. Dis Mon. 2017;63(2):45–8.PubMedCrossRefGoogle Scholar
  7. D’Alessandro LP, Forster DJ, Rao NA. Anterior uveitis and hypopyon. Am J Ophthalmol. 1991;112(3):317–21.PubMedCrossRefGoogle Scholar
  8. Dawson CR, Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol. 1976;21:121–35.PubMedCrossRefGoogle Scholar
  9. Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19(3):227–34.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–88.CrossRefGoogle Scholar
  12. Garg P, Roy A, Sharma S. Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. Curr Opin Ophthalmol. 2017;28(1):67–72.PubMedCrossRefGoogle Scholar
  13. Kopplin LJ, Mount G, Suhler EB. Review for disease of the year: epidemiology of HLA-B27 associated ocular disorders, ocular immunology and inflammation. Ocul Immunol Inflamm. 2016;24(4):470–5.PubMedCrossRefGoogle Scholar
  14. London NJ, Garg SJ, Moorthy RS, Cunningham ET. Drug-induced uveitis. J Ophthalmic Inflamm Infect. 2013;3(1):43.  https://doi.org/10.1186/1869-5760-3–43
  15. Papaliodis GN, Montezuma SR. Pseudo-hypopyon as the presenting feature of recurrent B-cell lymphoma. Ocul Immunol Inflamm. 2008;16(3):121–2.PubMedCrossRefGoogle Scholar
  16. Pathanapitoon K, Dodds EM, Cunningham Jr ET, Rothova A. Clinical spectrum of HLA-B27-associated ocular inflammation. Ocul Immunol Inflamm. 2017;25(4):569–76.PubMedCrossRefGoogle Scholar
  17. Petrowski JT. Uveitis associated with rifabutin therapy: a clinical alert. J Am Optom Assoc. 1996;67(11):693–6.PubMedGoogle Scholar
  18. Ramsay A, Lightman S. Hypopyon uveitis. Surv Ophthalmol. 2001;46(1):1–18. Review.PubMedCrossRefGoogle Scholar
  19. Rathinam S, Prajna L. Hypopyon in leprosy uveitis. J Postgrad Med. 2007;53(1):46–7.PubMedCrossRefGoogle Scholar
  20. Rosselet E, Gailloud C, Verrey F. Retinoblastoma and hypopyon. Ophthalmologica. 1970;161(2):139–44.PubMedCrossRefGoogle Scholar
  21. Searl SS, Moazed K, Albert DM, Marcus LC. Ocular toxocariasis presenting as leukocoria in a patient with low ELISA titer to Toxocara canis. Ophthalmology. 1981;88(12):1302–6.PubMedCrossRefGoogle Scholar
  22. Shetty SB, Devulapally SH, Murali S, Walinjkar JA, Biswas J. Tuberculous uveitis presenting as pigmented hypopyon – a case report. Am J Ophthalmol Case Rep. 2017;12(7):1–3.Google Scholar
  23. Sheu SJ. Endophthalmitis. Korean J Ophthalmol. 2017;31(4):283–9.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Sinha MK, Narayanan R, Chhablani JK. Hypopyon uveitis following panretinal photocoagulation in a diabetic patient. Semin Ophthalmol. 2014;29(3):166–8.PubMedCrossRefGoogle Scholar
  25. Sudharshan S, Kumari A, Biswas J. Bilateral hypopyon as the presenting feature of chronic myeloid leukemia. Ocul Immunol Inflamm. 2008;16(5):244–6.PubMedCrossRefGoogle Scholar
  26. Touitou V, Bodaghi B, Thepot S, Chapiro E, Nguyen-Khac F, Charlotte F, LeHoang P, Maloum K. When the eye gives it all: diagnosis of relapsing acute myeloblastic leukemia with anterior chamber tap of a chronic hypopyon. Am J Hematol. 2014;89(8):858–9.PubMedCrossRefGoogle Scholar
  27. Tugal-Tutkun I, Onal S, Ozyazgan Y, Soylu M, Akman M. Validity and agreement of uveitis experts in interpretation of ocular photographs for diagnosis of Behçet uveitis. Ocul Immunol Inflamm. 2014;22(6):461–8.PubMedCrossRefGoogle Scholar
  28. Tyagi M, Ambiya V, Rani PK. Hypopyon uveitis following panretinal photocoagulation. BMJ Case Rep. 2016;2016: bcr2016215949.Google Scholar
  29. Tyagi M, Govindhari V, Pappuru RR, Ambiya V. Bilateral hypopyon uveitis in chronic myeloid leukemia. Ocul Oncol Pathol. 2017;4(1):12–5.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Velu J, Agarwal S, Gupta V, Sharma K, Sharma A, Gupta A. Hypopyon uveitis-a rare presentation of intraocular tuberculosis. Ocul Immunol Inflamm. 2013;21(3):251–3.PubMedCrossRefGoogle Scholar
  31. Winegarner A, Hashida N, Koh S, Nishida K. Hemorrhagic hypopyon as presenting feature of intravascular lymphoma, a case report. BMC Ophthalmol. 2017;17(1):195.  https://doi.org/10.1186/s12886-017-0591-3
  32. Wormald RP, Harper JI. Bilateral black hypopyon in a patient with self-healing cutaneous malignant melanoma. Br J Ophthalmol. 1983;67(4):231–5.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Zaidi AA, Ying GS, Daniel E, et al. Systemic immunosuppressive therapy for eye diseases cohort study. Hypopyon in patients with uveitis. Ophthalmology. 2010;117(2):366–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature India Private Limited 2019

Authors and Affiliations

  • Aniruddha Agarwal
    • 1
  • Ilaria Testi
    • 2
  • Ankur Singh
    • 1
  • Vishali Gupta
    • 1
    Email author
  1. 1.Advanced Eye Center, Post Graduate Institute of Medicine and Research (PGIMER)ChandigarhIndia
  2. 2.Department of OphthalmologyUniversity of PadovaPadovaItaly

Personalised recommendations